16,558 findings · published 2017+
- CellularStrong
Nutrition before, during and after a game or a high-intensity training session plays a fundamental role in the recovery of the basketball player.
Practitioners should emphasize nutritional strategies for recovery in basketball training and competition.
Supports 2019 - Metabolic adaptationStrong
Type of nutrient and food supplements are essential for a quicker recovery, in addition to their timing and dose.
Focus on specific nutrients and supplements, along with their timing, to enhance recovery.
Supports 2019 - NeuralStrong
Fatigue produced during a basketball game can be analyzed to offer practical solutions for recovery.
Analyzing fatigue can help develop targeted nutritional strategies for recovery.
Supports 2019 - CellularStrong
Exercise is a first-line prevention and intervention strategy for type 2 diabetes.
Practitioners should prioritize exercise as a key component in diabetes prevention and treatment.
Supports 2023 - Energy balanceStrong
The 'food labels & real-time feedback' and 'ordering' strategies had significantly positive main effects on overall diet quality of the shopping basket.
Implementing food labels with real-time feedback and ordering by nutritional quality can significantly enhance diet quality in online grocery shopping.
Supports 2022 - Energy balanceStrong
Combining 'food labels & real-time feedback' and 'ordering' interventions is more effective than using either intervention alone.
Using a combination of food labels with real-time feedback and ordering can significantly enhance diet quality in online grocery shopping.
Supports 2022 - Energy balanceStrong
Ad libitum energy intake was 689±73 kcal/d lower during the plant-based, low-fat diet compared to the animal-based, ketogenic diet (p<0.0001).
Practitioners may consider recommending a plant-based, low-fat diet for better appetite control and lower energy intake.
Supports 2020 - NeuralStrong
Traditional-set structure (TRAD) resulted in significantly greater velocity loss magnitude (g = 1.50) compared to cluster-set structure (CLUS).
Practitioners may consider using traditional-set structures to enhance performance metrics like velocity loss.
Supports 2021 - CellularStrong
TRAD showed greater muscle thickness of the proximal pectoralis major (g = -0.34) compared to CLUS.
Using traditional-set structures may lead to better hypertrophy outcomes in the proximal pectoralis major.
Supports 2021 - Energy balanceStrong
Individuals with greater weight loss reported consuming higher proportions of low-energy-dense foods and lower proportions of high-energy-dense foods than individuals with less weight loss at 4 months and 18 months.
Encouraging the consumption of low-energy-dense foods may enhance weight loss outcomes.
Supports 2021 - Energy balanceStrong
At 18 months, individuals with greater weight loss had higher fruit and vegetable intake, dietary quality, nutrition knowledge, and healthier food choice.
Improving nutrition knowledge and food choices may support weight loss efforts.
Supports 2021 - NeuralStrong
Only nutrition knowledge and food choice were associated with weight loss at 18 months.
Focusing on enhancing nutrition knowledge and food choices can be crucial for weight loss success.
Supports 2021 - Metabolic adaptationStrong
Time-dependent increases were detected from baseline to week 8 for muscle thickness and strength.
Resistance training leads to significant improvements in muscle thickness and strength over 8 weeks.
Supports 2019 - Energy balanceStrong
Being in the top versus bottom quartile of the carbohydrate quality index (CQI) is associated with a higher nutrient adequacy ratio (NAR) for folic acid (OR: 3.20), vitamin A (OR: 3.66), magnesium (OR: 5.94), and vitamin C (OR: 7.85).
Practitioners should consider promoting higher carbohydrate quality to improve micronutrient intake among adults.
Supports 2021 - Energy balanceStrong
Increasing the consumption of total fiber and solid carbohydrates while decreasing the glycemic index can improve micronutrient intake adequacy.
Dietary interventions should focus on fiber and solid carbohydrate intake to enhance micronutrient adequacy.
Supports 2021 - HormonalStrong
The use of long‐acting incretin‐based therapies, such as semaglutide, has increased due to their benefits for glycemic control in diabetes, cardiovascular risk reduction, and weight management.
Clinicians should consider the benefits of semaglutide for patients with diabetes and weight management needs.
Supports 2024 - HormonalStrong
Retatrutide exhibited significant reductions in glycated hemoglobin (HbA1c) and dose-dependent weight loss in individuals with type 2 diabetes mellitus (T2DM).
Retatrutide may be an effective treatment option for managing HbA1c and weight in T2DM patients.
Supports 2023 - HormonalStrong
In non-T2DM individuals, retatrutide produced substantial weight loss and improved glucose levels.
Retatrutide may also benefit non-T2DM individuals seeking weight loss and improved glucose control.
Supports 2023 - HormonalStrong
Behavioral interventions and pharmacological therapies may be effective strategies for weight management in PWH.
Integrating behavioral and pharmacological approaches may enhance weight management efforts in PWH.
Supports 2023 - HormonalStrong
New glucose-lowering drugs, such as sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists, have been confirmed to reduce weight and preserve kidney function.
Clinicians may consider these new drugs as effective treatment options for managing ORG.
Supports 2024 - HormonalStrong
Addition of glucagon receptor agonism enhances weight loss, reduces liver fat, and ameliorates dyslipidemia.
Practitioners should consider glucagon receptor agonists for their potential benefits in weight loss and metabolic health.
Supports 2024 - Metabolic adaptationStrong
SGLT-2 inhibitors and GLP-1 receptor agonists (GLP-1RAs) lead to a decline in body weight ranging from 1.5 to 5 kg.
Practitioners can consider SGLT-2 inhibitors and GLP-1RAs as effective options for weight loss in patients.
Supports 2023 - HormonalStrong
Liraglutide and semaglutide may provide benefits for weight loss and glycaemic control in people living with HIV.
Practitioners may consider liraglutide and semaglutide for weight management in HIV patients, particularly those with diabetes.
Supports 2023 - HormonalStrong
The STEP HFpEF and SELECT trials demonstrated that semaglutide improves clinical outcomes in obese HFpEF patients and reduces cardiovascular and heart failure events in non-diabetic obese patients.
Practitioners should consider semaglutide as a treatment option for improving outcomes in obese HFpEF patients.
Supports 2024